Abstract
We retrospectively analyzed the clinical and microbiological characteristics of adult patients with hematological malignancy and nontuberculous mycobacteria (NTM) infections from 2001 to 2010. During the study period, 50 patients with hematological malignancy and tuberculosis (TB) were also evaluated. Among 2,846 patients with hematological malignancy, 34 (1.2%) patients had NTM infections. Mycobacterium avium-intracellulare complex (13 patients, 38%) was the most commonly isolated species, followed by M. abscessus (21%), M. fortuitum (18%), and M. kansasii (18%). Twenty-six patients had pulmonary NTM infection and eight patients had disseminated disease. Neutropenia was more frequently encountered among patients with disseminated NTM disease (p = 0.007) at diagnosis than among patients with pulmonary disease only. Twenty-five (74%) patients received adequate initial antibiotic treatment. Five of the 34 patients died within 30 days after diagnosis. Cox regression multivariate analysis showed that chronic kidney disease (p = 0.017) and neutropenia at diagnosis (p = 0.032) were independent prognostic factors of NTM infection in patients with hematological malignancy. Patients with NTM infection had higher absolute neutrophil counts at diagnosis (p = 0.003) and a higher 30-day mortality rate (15% vs. 2%, p = 0.025) than TB patients. Hematological patients with chronic kidney disease and febrile neutropenia who developed NTM infection had significant worse prognosis than patients with TB infection.
Similar content being viewed by others
References
Wagner D, Young LS (2004) Nontuberculous mycobacterial infections: a clinical review. Infection 32:257–270
Jarzembowski JA, Young MB (2008) Nontuberculous mycobacterial infections. Arch Pathol Lab Med 132:1333–1341
Khan K, Wang J, Marras TK (2007) Nontuberculous mycobacterial sensitization in the United States: national trends over three decades. Am J Respir Crit Care Med 176:306–313
Marras TK, Chedore P, Ying AM, Jamieson F (2007) Isolation prevalence of pulmonary non-tuberculous mycobacteria in Ontario, 1997–2003. Thorax 62:661–666
Simons S, van Ingen J, Hsueh PR, Van Hung N, Dekhuijzen PN, Boeree MJ et al (2011) Nontuberculous mycobacteria in respiratory tract infections, eastern Asia. Emerg Infect Dis 17:343–349
Lai CC, Tan CK, Chou CH, Hsu HL, Liao CH, Huang YT et al (2010) Increasing incidence of nontuberculous mycobacteria, Taiwan, 2000–2008. Emerg Infect Dis 16:294–296
Doucette K, Fishman JA (2004) Nontuberculous mycobacterial infection in hematopoietic stem cell and solid organ transplant recipients. Clin Infect Dis 38:1428–1439
Au WY, Cheng VC, Ho PL, Yuen KY, Hung I, Ma SY et al (2003) Nontuberculous mycobacterial infections in Chinese hematopoietic stem cell transplantation recipients. Bone Marrow Transplant 32:709–714
Almyroudis NG, Fabian J, Hahn T, Segal BH, Wetzler M, McCarthy PL Jr (2009) Late infectious complications after cord blood stem cell transplantation. Eur J Clin Microbiol Infect Dis 28:1405–1408
Weinstock DM, Feinstein MB, Sepkowitz KA, Jakubowski A (2003) High rates of infection and colonization by nontuberculous mycobacteria after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 31:1015–1021
Levendoglu-Tugal O, Munoz J, Brudnicki A, Fevzi Ozkaynak M, Sandoval C, Jayabose S (1998) Infections due to nontuberculous mycobacteria in children with leukemia. Clin Infect Dis 27:1227–1230
Suryanarayan K, Campbell J, Eskenazi AE (2002) Nontuberculous mycobacterial infections in pediatric acute leukemia. J Pediatr Hematol Oncol 24:558–560
Damsker B, Bottone EJ, Deligdisch L (1982) Mycobacterium xenopi: infection in an immunocompromised host. Hum Pathol 13:866–870
Chen CY, Tang JL, Hsueh PR, Yao M, Huang SY, Chen YC et al (2004) Trends and antimicrobial resistance of pathogens causing bloodstream infections among febrile neutropenic adults with hematological malignancy. J Formos Med Assoc 103:526–532
Chen CY, Tsay W, Tang JL, Tien HF, Chen YC, Chang SC et al (2010) Epidemiology of bloodstream infections in patients with haematological malignancies with and without neutropenia. Epidemiol Infect 138:1044–1051
Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F et al (2007) An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 175:367–416
Ergin A, Hascelik G (2004) Non tuberculous mycobacteria (NTM) in patients with underlying diseases: results obtained by using polymerase chain reaction-restriction enzyme analysis between 1997–2002. New Microbiol 27:49–53
Ergin A, Kocagoz T, Us D (2000) Evaluation of 120 mycobacterial strains isolated from clinical specimens to the species level by polymerase chain reaction-restriction enzyme analysis. Scand J Infect Dis 32:657–662
Sexton P, Harrison AC (2008) Susceptibility to nontuberculous mycobacterial lung disease. Eur Respir J 31:1322–1333
Lin KH, Wang JH, Peng NJ (2008) Disseminated nontuberculous mycobacterial infection mimic metastases on PET/CT scan. Clin Nucl Med 33:276–277
Hsiao CH, Lin YT, Lai CC, Chou CH, Hsueh PR (2010) Identification of nontuberculous mycobacterial infection by IS6110 and hsp65 gene analysis on lung tissues. Diagn Microbiol Infect Dis 68:241–246
Taiwo B, Glassroth J (2010) Nontuberculous mycobacterial lung diseases. Infect Dis Clin North Am 24:769–789
Funding
Funding of this study was provided in part by a grant (100-S1526) from the Department of Medical Research, National Taiwan University Hospital, Taiwan.
Conflicts of interest
None of the authors has anything to declare.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chen, CY., Sheng, WH., Lai, CC. et al. Mycobacterial infections in adult patients with hematological malignancy. Eur J Clin Microbiol Infect Dis 31, 1059–1066 (2012). https://doi.org/10.1007/s10096-011-1407-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-011-1407-7